| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/28/2002 | WO2002024745A2 Method for detecting tumor cells |
| 03/28/2002 | WO2002024733A2 Human polynucleotides and polypeptides encoded thereby |
| 03/28/2002 | WO2002024726A2 Olfactory and pheromones g-protein coupled receptors |
| 03/28/2002 | WO2002024724A1 PREPARATION OF CAPPED mRNA |
| 03/28/2002 | WO2002024719A1 21 human secreted proteins |
| 03/28/2002 | WO2002024221A2 Notch receptor agonists and uses |
| 03/28/2002 | WO2002024056A2 METHODS AND COMPOSITIONS FOR DETECTING CANCERS ASSOCIATED WITH METHYLATION OF hMLH1PROMOTER DNA |
| 03/28/2002 | WO2002000918A3 Biosensor and method for production thereof |
| 03/28/2002 | WO2001094952A3 Methods and compositions for modulating oxidized ldl transport |
| 03/28/2002 | WO2001094546A3 Primer extension using a mixture of labelled and unlabelled nucleotides |
| 03/28/2002 | WO2001094365A3 Haplotypes of the phkg2 gene |
| 03/28/2002 | WO2001092569A3 Formulation for polymerase chain reaction and vessel containing same |
| 03/28/2002 | WO2001090153A8 Reagents for cell selection and methods of use |
| 03/28/2002 | WO2001090127A3 Haplotypes of the hoxd3 gene |
| 03/28/2002 | WO2001088177A3 Stain solution, which is devoid of phenol, for bacteria |
| 03/28/2002 | WO2001088087A3 Microfluidic channel embryo and/or oocyte handling, analysis and biological evaluation |
| 03/28/2002 | WO2001087905A3 Haplotypes of the adora2a gene |
| 03/28/2002 | WO2001087904A3 Haplotypes of the gpr4 gene |
| 03/28/2002 | WO2001085985A8 Assay for detecting, measuring and monitoring the activities and concentrations of proteins and methods of use thereof |
| 03/28/2002 | WO2001085772A3 Virulence genes, proteins, and their use |
| 03/28/2002 | WO2001085770A3 Sentinel virus ii |
| 03/28/2002 | WO2001085762B1 Cancer diagnosis and assays for screening anti-cancer agents |
| 03/28/2002 | WO2001080719A3 Methods and composition for the diagnosis of schizophrenia |
| 03/28/2002 | WO2001080711A3 Method of evaluating a risk of a subject of developing vascular complications |
| 03/28/2002 | WO2001079522A3 Screening assay methods and systems using target pooling |
| 03/28/2002 | WO2001079459A3 Polypeptides having haloperoxidase activity |
| 03/28/2002 | WO2001079249A3 Peptide nucleic acid derivatives with a negative charge, agents and methods for producing them |
| 03/28/2002 | WO2001077170A3 Multiprotein-complexes comprising a nmda receptor and uses thereof |
| 03/28/2002 | WO2001077150A3 Serine-threonine kinase |
| 03/28/2002 | WO2001074859A3 A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 03/28/2002 | WO2001073114A3 Reagents and methods for detecting a reduced cofactor |
| 03/28/2002 | WO2001072966A3 Haplotypes of the pltp gene |
| 03/28/2002 | WO2001070977A3 Fibroblast growth factor receptor-like molecules and uses thereof |
| 03/28/2002 | WO2001070777A3 Leafy cotyledon2 genes and their uses |
| 03/28/2002 | WO2001069247A3 Methods of making and using microarrays of anti-ligands for the analysis of protein expression in cells |
| 03/28/2002 | WO2001069199A3 Methods of detecting cancer using cellular autofluorescence |
| 03/28/2002 | WO2001066790A3 Detection of aspergillus fumigatus |
| 03/28/2002 | WO2001066775A3 Dna joining method |
| 03/28/2002 | WO2001066107A3 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases |
| 03/28/2002 | WO2001064958A3 Modified oligonucleotides for mismatch discrimination |
| 03/28/2002 | WO2001064945A3 Novel dna chips |
| 03/28/2002 | WO2001062925A3 103p2d6: tissue specific protein highly expressed in various cancers |
| 03/28/2002 | WO2001062793A3 Estrogen receptor beta variants and methods of detection thereof |
| 03/28/2002 | WO2001061033A3 Multiplex ligatable probe amplification |
| 03/28/2002 | WO2001059156A3 DETECTION OF BINDING OF CHARGED SPECIES USING pH- OR POTENTIAL-SENSITIVE PROBES |
| 03/28/2002 | WO2001057194A3 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 03/28/2002 | WO2001057182A3 Nucleic acids, proteins, and antibodies |
| 03/28/2002 | WO2001055356A3 Human protein kinases and protein kinase-like enzymes |
| 03/28/2002 | WO2001051642A3 Dna modification proteins |
| 03/28/2002 | WO2001049871A3 Process for finding a protease inhibitor |
| 03/28/2002 | WO2001038486A3 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 03/28/2002 | WO2001036674A3 Diagnostic methods for detection of prostate disorders |
| 03/28/2002 | WO2001032885A3 Human lipase |
| 03/28/2002 | WO2001032702B1 Molecular structure of rhd negative locus |
| 03/28/2002 | WO2001029240A3 Regeneration |
| 03/28/2002 | WO2001011079A3 Nucleic acid analysis method and system |
| 03/28/2002 | WO2001009183A3 Polymorphisms in the human mdr-1 gene and applications thereof |
| 03/28/2002 | WO2000071754A3 Methods for diagnosing, preventing, and treating developmental disorders due to a combination of genetic and environmental factors |
| 03/28/2002 | WO2000070088A3 Immobilization of unmodified biopolymers to acyl fluoride activated substrates |
| 03/28/2002 | WO2000068431A3 Dna-based steganography |
| 03/28/2002 | WO2000066784A3 Growth hormone-regulatable brown adipose tissue genes, corresponding proteins and uses thereof |
| 03/28/2002 | WO2000063419A9 Combinatorial chemical library supports having indicia at coding positions and methods of use |
| 03/28/2002 | WO2000042912A9 Polarized light scattering spectroscopy of tissue |
| 03/28/2002 | US20020038471 Use of VLCFAE for identifying herbicidally active compounds |
| 03/28/2002 | US20020038469 Delayed progression to aids by a missense allele of the ccr2 gene |
| 03/28/2002 | US20020038464 Novel glucose transporter/sensor protein and uses thereof |
| 03/28/2002 | US20020038463 Methods for screening and identifying host pathogen defense genes |
| 03/28/2002 | US20020038185 Method for indicating relationship between cDNA sequence and genome recording medium, sequencer apparatus, and method for designing a primer |
| 03/28/2002 | US20020038021 Eplerenone crystalline form exhibiting enhanced dissolution rate |
| 03/28/2002 | US20020038016 Decoy probes |
| 03/28/2002 | US20020038015 Polynucleotide probes for detection and quantitation of candida albicans and candida dubliniensis |
| 03/28/2002 | US20020038006 Human extracellular matrix proteins |
| 03/28/2002 | US20020038005 For using the genes, for example in microorganisms to control insect pests or in transgenic plants to confer insect resistance |
| 03/28/2002 | US20020038000 Systematic polypeptide evolution by reverse translation |
| 03/28/2002 | US20020037869 Human bad polypeptides, encoding nucleic acids and methods of use |
| 03/28/2002 | US20020037868 Diagnosis using antibodies |
| 03/28/2002 | US20020037851 Codes with nucleic acids; antiinflammatory agents |
| 03/28/2002 | US20020037850 Genetic engineering; binding to antibodies |
| 03/28/2002 | US20020037840 Fusion protein |
| 03/28/2002 | US20020037834 Process control; low temperature |
| 03/28/2002 | US20020037590 Detecting microorganisms in sample; obtain swab, swab surface, recover sample, recover sample, detect preferential carbohydrate, detect microorganism |
| 03/28/2002 | US20020037589 Detection of nucleic acids in red blood cells by flow cytometry by employing fluorescent, nucleic acid binidng cyanine dye |
| 03/28/2002 | US20020037582 Potential effector for the grb7 family of signalling proteins |
| 03/28/2002 | US20020037572 Novel mammalian secreted group III phospholipase A2 |
| 03/28/2002 | US20020037570 Alpha 1,2-fucosyltransferase |
| 03/28/2002 | US20020037565 Purifying and quantifying adenovirus by ion-exchange chromatography; for example, identifying different adenovirus serotypes |
| 03/28/2002 | US20020037556 Heliothis virescens ultraspiracle (USP) protein |
| 03/28/2002 | US20020037549 ABC transport polynucleotides, polypeptides, and antibodies |
| 03/28/2002 | US20020037548 Peptide; for use as diagnostic tool in human therapeutics |
| 03/28/2002 | US20020037546 Tests which evaluate the efficieny and accuracy of bacterial removal from apparatus |
| 03/28/2002 | US20020037545 Glycine and S-adenosylmethionine (SAM) are reacted with glycine N-methyltransferase, sarcosine and S-adenosyl homocysteine products are measured in the presence of a sample and a control; folate inhibits the enzyme |
| 03/28/2002 | US20020037542 Method and apparatus for detecting cancerous cells using molecules that change electrophoretic mobility |
| 03/28/2002 | US20020037541 Isolated nucleic acid molecules associated with gastric cancer and methods for diagnosing and treating gastric cancer |
| 03/28/2002 | US20020037540 Nucleotide sequences coding preferential tumor markers; for use tools in tumor detection and treatment |
| 03/28/2002 | US20020037538 Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis |
| 03/28/2002 | US20020037537 Measuring activity of endothelial growth factor modulator; obtain modulator, incubate with kinase, isolate phosphorylated substrate, remove label, detecting adjustment in kinase activity |
| 03/28/2002 | US20020037532 Affinity selected signature peptides for protein identification and quantification |
| 03/28/2002 | US20020037530 Detection of binding reactions using labels detected by mediated catalytic electrochemistry |
| 03/28/2002 | US20020037528 Method for detecting procoagulant genetic and metabolic conditions associated with, and potentially predispositional for, activation of the coagulation response |
| 03/28/2002 | US20020037526 Integrated biomolecule sensor, method and apparatus for fabricating the sensor, and method and apparatus for detecting biomolecules using the sensor |